In our literature search, we found a case report of a previously Trastuzumab-treated HER2-positive breast cancer relapsed with pulmonary lymphangitis carcinomatosis with benefit to Trastuzumab-emtansine therapy [28]. This evidence concerns the gene ERBB2 and breast carcinoma.